Showing results (381-390 of 608) with videos related to

Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 20, 2021
Clinical features and outcomes of COVID-19 despite SARS-CoV-2 vaccination in people with multiple sclerosisDeja R Rose, Ahmad Z Mahadeen, Alise K Carlson, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 20, 2021
Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapyAudrey Rico, Laetitia Ninove, Adil Maarouf, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 21, 2022
Quantitative MRI findings indicate diffuse white matter damage in Susac SyndromeP Johnson, J K Chan, I M Vavasour, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 27, 2022
Development of an indicator of smoking status for people with multiple sclerosis in administrative dataRuth Ann Marrie, Qier Tan, Okechukwu Ekuma, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 28, 2022
Extended Interval Dosing Natalizumab and impact on neuropsychological deficits in Relapsing-Remitting Multiple SclerosisEileen J McManus, Karen M Clark, Christopher Frampton, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 26, 2019
Predictors of hospital-based multidisciplinary rehabilitation effects in persons with multiple sclerosis: a large-scale, single-centre studyElisabetta Groppo, Alessio Signori, Maria Pia Sormani, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 4, 2022
Comparing the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis: A cost-consequence analysis from a societal perspective in GermanyDominik Koeditz, Juergen Frensch, Martin Bierbaum, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 7, 2018
Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disordersSusanna Asseyer, Felix Schmidt, Claudia Chien, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 18, 2018
Differences in clinical features between optic neuritis in neuromyelitis optica spectrum disorders and in multiple sclerosisJindapa Srikajon, Sasitorn Siritho, Chanon Ngamsombat, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 18, 2018
Reference videos reduce variability of motor dysfunction assessments in multiple sclerosisMarcus D'Souza, Saskia Steinheimer, Jonas Dorn, et al.
Pageof 61